International Research in Chinese Medicine

Objective Vulnerable groups in clinical trials may face more risks, so they need more attention and protection. Methods Through the existing regulations on clinical trials, vulnerable subjects are identified, and the characteristics and potential risks of this group are analyzed, and corresponding protection measures are proposed. Results The regulations on vulnerable groups need to be improved, and all parties involved in clinical trials also need to make more efforts to protect vulnerable subjects. Conclusion The overall quality of clinical trials is expected to be further improved by ensuring the participation of vulnerable groups in clinical trials.

Clinical trials; Vulnerable groups; Subjects; Protection measures